← SynDRA
RO-0622
SynDRA canonical compound SYN0018882 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Mechanism of action | nucleoside reverse transcriptase inhibitor |
|---|
| Indication | human immunodeficiency virus (hiv-1) |
|---|
| Disease area | infectious disease |
|---|
Cross-references
Synonyms
- RO 0622
- Azvudine
- IJ2XP0ID0K
- 2'-deoxy-2'-beta-fluoro-4'-azidocytidine
- RefChem:116173
- DTXCID001513333
- 4'-C-azido-2'-deoxy-2'-fluoro-beta-D-arabinocytidine
- 4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinocytidine
- Azvudine?
- AZVUDINE [WHO-DD]
- orb1308591
- SCHEMBL15866623
- GTPL13479
- GLXC-25994
- EX-A7288
- FNC
- MSK178922
- AKOS040741284
- EBC-656269
- NA32212
- AC-38118
- DA-61461
- HY-19314
- TS-07964
- CS-0015081
- F86375
- T14489
- 2'-DEOXY-2'-.BETA.-FLUORO-4'-AZIDOCYTIDINE
- 4'-C-Azido-2'-deoxy-2'-fluoro-?-D-arabinocytidine
- Azvudine; FNC; RO-0622; RO 0622; RO0622
- T38727
- PD157898
- AKOS040756648
- Azvudine (hydrochloride)
- orb1691815
- HY-19314A
- MS-24788
- G17370
- CS-0127902
- Azvudine hydrochloride
Look up RO-0622 in the interactive SynDRA portal →